Skip to main content
. 2022 Dec 14;5(2):100584. doi: 10.1016/j.xkme.2022.100584

Figure 3.

Figure 3

International parathyroid hormone (PTH) trends among in-center hemodialysis patients, from 2002-2021.

[DOPPS phases 2-7 included facilities from the United States, Japan, and 7 European countries (Belgium, France, Germany, Italy, Spain, Sweden, United Kingdom). The period covers 121,898 patient-months from the United States, 18,845 from Japan, and 18,845 from Europe.]